Participants 84 106 3
advanced breast cancer
Participants 184 220 9
60 women with advanced breast cancer
Participants 485 676 9
All patients were post-menopausal, previously untreated with hormone therapy, and with tumor receptor status determined immediately before randomization; all had objectively evaluable lesions
Participants 833 902 4
Thirty-one and 29 patients were included respectively in arms A and B
